Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-06-068655
Filing Date
2006-03-30
Accepted
2006-03-30 16:24:53
Documents
6
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 FOR THE FISCAL YEAR ENDED DECEMEBER 31, 2005 d10k.htm 10-K 1073173
2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 1554
3 CERTIFICATION OF JOSEPH K. BELANOFF, PURSUANT TO RULE 13A-14(A) dex311.htm EX-31.1 8700
4 CERTIFICATION OF FRED KURLAND, PURSUANT TO RULE 13A-14(A) dex312.htm EX-31.2 8646
5 CERTIFICATION OF JOSEPH K. BELANOFF, PURSUANT TO 18 U.S.C SECTION 1350 dex321.htm EX-32.1 3828
6 CERTIFICATION OF FRED KURLAND, PURSUANT TO 18 U.S.C SECTION 1350 dex322.htm EX-32.2 3815
  Complete submission text file 0001193125-06-068655.txt   1100938
Mailing Address
Business Address 275 MIDDLEFIELD ROAD SUITE A MENLO PARK CA 94025
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

EIN.: 770487658
Type: 10-K | Act: 34 | File No.: 000-50679 | Film No.: 06723511
SIC: 2834 Pharmaceutical Preparations